Evidence mapPaperPMID 42548822Full record

ArticleiScience2026

Brazilian biorepository to support genome-wide association studies of colorectal, breast, and cervical cancer.

Lázaro Antonio Campanha Novaes, Rafaela Dias Oliveira, Isabella Lemuqui Tegami, Maria Fernanda Santiago Gonçalves, Howard Lopes Ribeiro Junior, Mariana Bisarro Dos Reis, Daniel Antunes Moreno, Júlio Possati-Resende, Florinda Santos, Cláudio Hashimoto and 10 more

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Lázaro Antonio Campanha NovaesMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Rafaela Dias OliveiraLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Isabella Lemuqui TegamiMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Maria Fernanda Santiago GonçalvesMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Howard Lopes Ribeiro JuniorMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Mariana Bisarro Dos ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Daniel Antunes MorenoMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Júlio Possati-ResendeDepartment of Prevention, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Florinda SantosDepartment of Clinical Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Cláudio HashimotoDepartment of Prevention, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Augusto AntoniazziDepartment of Oncogenetics, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Stefano BaraldoDepartment of Prevention, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Luis RomagnoloDepartment of Lower Surgery, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Ricardo Dos ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Luciane Sussuchi da SilvaMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Letícia Ferro LealMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Denise Peixoto GuimarãesMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Márcia Maria Chiquitelli MarquesMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Adeylson Guimarães RibeiroMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.
Rui Manuel ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo State, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have identified numerous genetic variants associated with cancer susceptibility. However, over 90% of participants are of European ancestry, limiting the applicability to highly admixed groups such as Brazilians. To address this gap, we established a large-scale Brazilian biorepository to support cancer GWAS, replication studies, and polygenic risk score (PRS) evaluation for colorectal, breast, and cervical cancers. 4,062 participants have been enrolled, including cancer cases and cancer-free controls, yielding 39,700 blood-derived biospecimens. Genotyping was performed in 2,844 participants using the Axiom 850K PMDA array. All Brazilian states were represented, with the majority of participants from the Southeast region. Genetic ancestry inference confirmed Brazil's highly admixed genetic background, with predominant European, followed by African, Native American, and Asian contributions. This biorepository provides a scalable resource to enable replication of genetic associations, assess the transferability of polygenic risk scores, and advance precision medicine in underrepresented populations.

Indexed as

biorepositorybreast cancercancer genomicscervical cancercolorectal cancergenetic diversitygenome-wide association studiesprecision medicine

Identifiers

PMID42548822
PMCPMC13429900

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.